Covaxin gets emergency use approval for kids aged 2-18 years


New Delhi, Oct 12 (IANS): The Hyderabad-based pharma major Bharat Biotech's Covaxin has got the emergency use approval for children in the age group of 2 to 18 years from the Drugs Controller General of India (DCGA).

The Subject Expert Committee on Covid-19 gave the approval for the emergency use in the children.

The expert panel said in a statement, "After detailed deliberation, the committee recommended for grant of market authorisation of the vaccine for the age group of 2 to 18 years for restricted use in emergency situation."

Bharat Biotech had submitted the trial data of phase 2 and 3 of Covaxin on children in the beginning of this month to the apex body -- DCGI at the start of this month. The vaccine will be administered in two doses with 20 days of interval.

However, Bharat Biotech needs to submit safety data with due analysis every 15 days for the first two months and monthly thereafter.

Remarkably, the global health body World Health Organisation has not granted the emergency use authorisation to Covaxin. The World Health Organisation said last week that it will carry out the risk and benefit assessment next week with experts and take a final decision on the much awaited EUL to Covid vaccine Covaxin.

The WHO said in the last meeting, "WHO & an independent group of experts are scheduled to meet next week to carry out the risk/benefit assessment and come to a final decision whether to grant Emergency Use Listing to Covaxin".

Meanwhile, India continues to show the declining trends in the daily trajectory of Covid caseloads. India on Tuesday reported 14,313 fresh Covid cases in the last 24 hours, lowest recorded cases in the 224 days. Total 181 deaths have also been reported in the same time span, pushing the death toll to 4,50,963, the Union Health Ministry said.

The Active Caseload is presently 2,14,900, which is the lowest in 212 days. The active Covid cases presently constitute 0.63 per cent of the country's total positive cases.

 

 

 

 

 

  

Top Stories

Comment on this article

  • Dev, Mangalore

    Tue, Oct 12 2021

    Yes doctor, according to the world wide data kids under 25 have no risk at all. Out of 10 lakh 1 comorbid kid had serious infection and treatments in hospital while vacs cause more injuries to kids like out of thousand 9 are likely to suffer adverse vaccine injurand even death, as harm outweighs benefit I request parents not to lend your kids as human guinea pigs for an experimental jabs. U S Novavax is a traditional form of vaccine in trial stages and good news is our Serum Institute is contracted to produce their vaccines after they get the licence. I recommend it to those who are vulnerable if they don't contain toxic chemicals (according to my research at present it seems the safest with the method and contents like soap tŕee bark as adjuavant & nano spike using caterpillars and moths) but kids never need any unproven vaccines is my view point

    DisAgree Agree [2] Reply Report Abuse

  • kindheartbeats, Mangalore

    Tue, Oct 12 2021

    Getting approval within India is not big deal. Get approval from WHO. It is still not approved for international travel

    DisAgree [1] Agree [10] Reply Report Abuse

  • Ozy, Surathkal

    Tue, Oct 12 2021

    You can't travel any foreign countries by taking this vaccine.

    DisAgree Agree [6] Reply Report Abuse

  • Monty Dotor, Mangalore

    Tue, Oct 12 2021

    By this month end it will get approval by WHO, foreign manufacturers are responsible for the delay, so that they can sell their vaccines, and make a fast buck.

    DisAgree [1] Agree [2] Reply Report Abuse

  • Monty Dotor, Mangalore

    Tue, Oct 12 2021

    It is made in India, and made the traditional way like other vaccines which most of us have taken, so it should be safe . John and Dev may not agree with me.

    DisAgree [4] Agree [5] Reply Report Abuse


Leave a Comment

Title: Covaxin gets emergency use approval for kids aged 2-18 years



You have 2000 characters left.

Disclaimer:

Please write your correct name and email address. Kindly do not post any personal, abusive, defamatory, infringing, obscene, indecent, discriminatory or unlawful or similar comments. Daijiworld.com will not be responsible for any defamatory message posted under this article.

Please note that sending false messages to insult, defame, intimidate, mislead or deceive people or to intentionally cause public disorder is punishable under law. It is obligatory on Daijiworld to provide the IP address and other details of senders of such comments, to the authority concerned upon request.

Hence, sending offensive comments using daijiworld will be purely at your own risk, and in no way will Daijiworld.com be held responsible.


Security Validation

Enter the characters in the image